LUX Infusion has acquired Infuse IQ, a Wyoming-headquartered independent infusion therapy provider, as it continues building a national platform spanning ambulatory and home-based infusion services.
Infuse IQ operates six clinic locations and provides infusion and injection treatments across more than 10 medical specialties. Its services include flexible scheduling, insurance support, and co-pay assistance programs.
LUX said integrating Infuse IQ will expand patient access to its ambulatory infusion network while giving referring physicians additional clinical resources, faster therapy starts, insurance support, and data sharing.
The acquisition also advances LUX’s broader omnichannel strategy, which combines home infusion with ambulatory infusion centers. Its growing network extends from Alaska to the Southeast and additional U.S. markets.
KEY QUOTES:
“This acquisition is a reflection of our strategy to grow with purpose, partnering with organizations that share our values and raise the standard of care for patients who depend on infusion therapy. Infuse IQ has demonstrated exactly the kind of clinical excellence and patient-first culture that defines LUX Infusion.”
Ted Kramm, CEO of LUX Infusion
“Joining LUX Infusion marks an exciting new chapter for Infuse IQ and, most importantly, for the patients and providers we serve. LUX Infusion’s clinician-led approach, investment in technology, and deep commitment to the patient experience align with everything we have worked to build.”
Brian Zweben, CEO of Infuse IQ
